Why is Par Drugs & Che. falling/rising?

As of 15-Sep, Par Drugs & Chemicals Ltd is experiencing a decline in its stock price, currently at 105.77, which reflects a decrease of 2.87 points or 2.64%. The stock has underperformed its sector by 3.22% today, despite being higher than the 20-day, 50-day, and 100-day moving averages. Over the past week, the stock has shown a modest gain of 2.73%, but its year-to-date performance is significantly negative at -46.82%. The company has a low debt-to-equity ratio and an attractive return on equity of 14.6, yet it has faced negative results for the last three consecutive quarters, contributing to a substantial decline of 58.87% over the past year.
In the broader market context, the Sensex has increased by 1.20% over the past week, indicating that Par Drugs & Chemicals Ltd is lagging behind the market trends. Although the stock has shown some positive movement in the short term, its long-term growth prospects appear poor, with net sales and operating profit growth rates of only 12.10% and 1.10%, respectively, over the last five years. The significant drop in profits and the reliance on non-operating income further exacerbate concerns about the company's financial health, leading to its underperformance compared to the broader market, which has seen a negative return of only -1.13% over the past year.